Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 8, 1998, Pages 1203-1211

  Hulthe, Johannes ^a   Wikstrand, John ^a   Lidell, Aira ^a   Wendelhag, Inger ^a   Hansson, Göran K ^b   Wiklund, Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody titers; Familial hypercholesterolemia; Oxidized LDL

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FATTY ACID OXIDATION; FEMALE; FEMORAL ARTERY; HUMAN; IMMUNE RESPONSE; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0031817689     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.8.1203     Document Type: Article

References (11)

1. Hansson GK. Immune responses in atherosclerosis. In: Hansson GK, Libby P, eds. Immune Functions of the Vessel Wall. Amsterdam, Netherlands: Harwood Academic Publishers; 1996.
2. Stemme S, Faber B, Holm J, Bondjers G, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA. 1995;92:3893-3897.
3. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 1996;98:800-814.
4. Ylä-Hertluala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994;14:32-40.
5. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gunner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
6. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL. Distribution of oxidation-specific lipid protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 1990;10:336-349.
7. Bui M, Sack M, Moutsatsos G, Lu D, Katz P, McCown R, Breall J, Rackley C. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J. 1996;131: 663-667.
8. Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension; a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens. 1995; 13:129-138.
9. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vase Biol. 1995;15: 441-445.
10. Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med. 1994;154: 2605-2609.
11. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyssönen K, Palinski W, Witztum JL. Autoantibodies against oxidized LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887.